How to Buy Arrowhead Pharmaceuticals Stock
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
Arrowhead Pharmaceuticals stock last closed at $15.74, down 2.96% from the previous day, and has decreased 40.6% in one year. It has overperformed other stocks in the Biotechnology industry by 0.36 percentage points. Arrowhead Pharmaceuticals stock is currently +64.47% from its 52-week low of $9.57, and -48.24% from its 52-week high of $30.41.
As of Jun 13, 2025, there are 138.1M shares of ARWR outstanding. The market cap of ARWR is $2.17B. In the past 24 hours, 1.22M ARWR shares were traded.
How to Buy Arrowhead Pharmaceuticals Stock
Not sure how to invest in Arrowhead Pharmaceuticals stock? Here's how.
- Decide where to buy Arrowhead Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Arrowhead Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your payment method and add your details.
- Analyze Arrowhead Pharmaceuticals stock: The Arrowhead Pharmaceuticals ticker symbol is ARWR. Is Arrowhead Pharmaceuticals stock a good investment? Should you buy shares of ARWR? How do ARWR's underlying business fundamentals look? Do top analysts think Arrowhead Pharmaceuticals is a good buy? Why has ARWR's stock price moved recently? (Hint: Our stock analysis website can help you understand if ARWR is a good stock to buy).
- Execute your ARWR buy order: Decide if you will purchase ARWR shares at the current market price or use a limit order to buy ARWR shares at a particular price.
- Track your investment in ARWR: Create a watchlist to track your position in Arrowhead Pharmaceuticals stock.
Step 1: Decide where to buy Arrowhead Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy ARWR shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to invest in ARWR stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start your new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've created your account on investing apps, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring money into your new investment account.
Step 4: Analyze Arrowhead Pharmaceuticals stock
Once you have decided on the best place to buy Arrowhead Pharmaceuticals stock, it's absolutely critical to analyze their stock before you buy, so you can comprehend the risk as well as the opportunity.
Arrowhead Pharmaceuticals Metrics
ARWR Due Diligence Score
WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ARWR's stock page.
Is ARWR stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge ARWR's true value.
Using relative valuations metrics:
- ARWR could be undervalued based on its P/B ratio of 3.18x, relative to Biotechnology industry P/B ratio of 4.66x
You can access additional valuation research on ARWR's stock here.
ARWR Financial Health Overview
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the ARWR balance sheet.
- There are more short-term assets than long-term liabilities on the ARWR balance sheet.
Negative Financial Indicators:
- ARWR has a relatively high debt to equity ratio of 1.3.
- ARWR's operating cash flow of $61.15M allows it to safely service it's debt of $740.51M.
- ARWR earnings of -$78.54M is not sufficient to cover its interest payments.
- Total ARWR debt is higher than 5 years ago, relative to shareholder equity.
- ARWR profit margin has gone up by 13.01 percentage points in the past year, but the company is still unprofitable.
Do Wall Street analysts think it's a good time to buy ARWR stock
Out of 5 sell side analysts who monitor ARWR, the consensus analyst rating on Arrowhead Pharmaceuticals is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Arrowhead Pharmaceuticals stock forecast page.
Metrics for Advanced ARWR Traders
ARWR Earnings
Last year, ARWR revenue was $545.21M. During the past 5 year, ARWR's revenue has gone up by 31.44% per year. This was slower than the Biotechnology industry average of 43.24%.
You can analyze ARWR's earnings and revenue performance here.
What are ARWR executives and large shareholders up to?
In the past 12 months, executives and large shareholders at ARWR have sold more shares than they have bought.
Christopher Richard Anzalone, Chief Executive Officer of ARWR, was the latest ARWR insider to sell. They sold $583,692.00 worth of ARWR shares on Apr 11, 2025.
Research more about who owns ARWR stock here.
Does ARWR provide a stable income stream?
No, Arrowhead Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about ARWR
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your ARWR buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, place a limit order.
Hit the Open Trade button and your broker will execute your order.
If you want additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Track your investment in ARWR
Now that you own some shares in ARWR, you'll want to keep up with your stock purchase.
Create a watchlist to track the latest developments regarding your ARWR stock.
ARWR Feed
How to Buy Stock in Arrowhead Pharmaceuticals
To summarize, here are the 6 steps for buying Arrowhead Pharmaceuticals stock:
- Decide where to buy Arrowhead Pharmaceuticals stock
- Create your brokerage account
- Deposit funds into your investment account
- Analyze Arrowhead Pharmaceuticals stock
- Execute your ARWR buy order
- Track your investment in ARWR
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to monitor your new investment in Arrowhead Pharmaceuticals, add ARWR to your watchlist by clicking the button below.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.